Middle East and Africa Diabetic Foot Ulcer Treatment Market
No. of Pages: 169 | Report Code: TIPRE00024695 | Category: Life Sciences
No. of Pages: 169 | Report Code: TIPRE00024695 | Category: Life Sciences
MEA consists of three major countries namely United Arab Emirates (UAE), Saudi Arabia, South Africa, and Rest of Middle East and African region. The market is driven by the factors such as increasing diabetics, increasing prevalence of diabetes and related chronic wounds, and rise in the geriatric population. The UAE dominate the MEA market. UAE has initiated the production of local pharmaceutical medicines that are exported to countries such as Kuwait, Iran, and Bahrain. According to the UAE Federal Customs Authority, in 2018, Saudi Arabia and Iraq, and the above-listed countries were significant export markets for the UAE. Most pharmaceutical products are produced at the Dubai Science Park, covering health conditions such as diabetes-associated indications such as diabetic foot ulcers, cardiovascular diseases, psychiatric and neurological disorders, gastroenterological diseases, and others. In addition, various companies are involved in the production of generic medicines. Therefore, it is expected that producing medicines for the above-listed health conditions demand more of the Diabetic Foot Ulcer Treatment that is likely to accelerate the growth of the market in the country. Domestic and international companies are collaborating to launch various products in the UAE. For instance, in January 2020, GlaxoSmithKline plc and Neopharma have launched the first domestically produced batch of medicines. The companies have aimed to provide better access to drugs for the local patients. Moreover, the local production contributes to 5% of the total consumption of healthcare products locally. Thus, the factors mentioned above are expected to foster the growth of the market during the forecast period.
In case of COVID-19, MEA is highly affected especially Turkey. The COVID-19 pandemic has become the most significant challenge in the region. This challenge would be particularly frightening for the region's fragile and conflict-torn states, such as Iraq (1,091,954), Sudan (33,648), Israel (838,767), and Yemen (6,414), because it will result in reduced imports due to global trade disruptions, which will exacerbate shortages of medical supplies and other goods, resulting in significant price rises. The Middle East countries have registered a growth in the number of COVID cases in the last few days. The MEA region include countries such as South Africa, the UAE, Turkey, and Saudi Arabia. These countries have also registered a significant number of positive coronavirus infection cases. These countries are developing in terms of the healthcare industry. The countries in these regions are highly dependent on imported medicinal products from developed countries. The lockdown has affected the supply chain of various companies in these regions. However, as the crisis continues and government relaxations on the import of the Diabetic Foot Ulcer Treatment products are expected to witness significant growth in the number of orders. However, as per the wound international report in South Africa, there is increased demand for wound care products since the outbreak of coronavirus in the country. The number of visits and types of wound treated are being delayed and preferred mode of consultation is through telephone calls and WhatsApp. This is likely to favor the growth of the Diabetic Foot Ulcer Treatment market in this region. Furthermore, as vaccination in MEA region progresses the burden on healthcare system will get released slowly which is expected to support the demand for diabetic foot ulcer treatment products.
Strategic insights for the Middle East and Africa Diabetic Foot Ulcer Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 169.01 Million |
| Market Size by 2028 | US$ 244.73 Million |
| Global CAGR (2021 - 2028) | 5.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | Middle East and Africa
|
| Market leaders and key company profiles |
The geographic scope of the Middle East and Africa Diabetic Foot Ulcer Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The MEA diabetic foot ulcer treatment market is expected to grow from US$ 169.01 million in 2021 to US$ 244.73 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028. Escalating geriatric population is expected to drive the market. The elderly population is defined as a group of people aged 65 and over. Aging is poised to BE one of the most significant social transformations of the 21st century. The aging population is significantly observed issue in the MEA region. For instance, as per the Statistics, more than 20.3% of the population belonged to the age group of 65 and above in 2019, and this number is expected to reach a significant high by 2050. Older adults are more likely to be diabetic and are further likely to develop diabetic foot ulcers, and the chronic wounds are likely to have a severe effect on the quality of life of this group of population. The wound healing process is more prolonged in the aging population due to the basic biology underlying chronic wounds and age-associated changes in wound healing. Therefore, with the growing elderly population, the demand of advanced diabetic foot ulcer treatments would continue to increase in the coming years, which will drive the MEA market in coming years.
In terms of type, the advanced wound care dressings segment accounted for the largest share of the MEA diabetic foot ulcer treatment market in 2020. In terms of ulcer type, the neuro-ischemic ulcers segment held a larger market share of the MEA diabetic foot ulcer treatment market in 2020. Further, the hospitals segment held a larger share of the MEA diabetic foot ulcer treatment market based on end user in 2020.
A few major primary and secondary sources referred to for preparing this report on the MEA diabetic foot ulcer treatment market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are 3M; B. Braun Melsungen AG; Cardinal Health Inc; Coloplast Group; ConvaTec Group Plc; Medline Industries, Inc.; MiMedx; Mölnlycke Health Care AB.; Organogenesis Inc.; Smith & Nephew; and URGO.
The Middle East and Africa Diabetic Foot Ulcer Treatment Market is valued at US$ 169.01 Million in 2021, it is projected to reach US$ 244.73 Million by 2028.
As per our report Middle East and Africa Diabetic Foot Ulcer Treatment Market, the market size is valued at US$ 169.01 Million in 2021, projecting it to reach US$ 244.73 Million by 2028. This translates to a CAGR of approximately 5.4% during the forecast period.
The Middle East and Africa Diabetic Foot Ulcer Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Diabetic Foot Ulcer Treatment Market report:
The Middle East and Africa Diabetic Foot Ulcer Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Diabetic Foot Ulcer Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Diabetic Foot Ulcer Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Diabetic Foot Ulcer Treatment Market
